1[1]Rothschild AJ. Management of psychotic, treatment-resistant depression.Psychiatr Clin North Am, 1996, 19(2) :52.
2[2]Bersani G and Pozzi F. 5-HT2 receptor antagomsin in dysthymic disorder.Acta Psychiatr Scand,1991, 83(4) :8.
3[3]Tollefscn GD. A double-blind, controlled comparison of the novel antipsychotic olanzapine versus haloperidol or placebo on anxious and depressive symptoms accompanying schizophrenia. Biol Psychiatry, 1998, 43( 11 ):10.
5Sackeim HA,The definition and meaning of treatment resistant depression[J].J Clin Psychiatry,2001,62(Suppl,16):10-17.
6Jane L. Eisena, Maria AM, Anthony Pintoa, et al. Impact of obsessive--compulsive disorder on quality o{ life[J]. Compr Psychiatry, 2006,47 (4) : 270- 275.
7Jill N. Fenske, Thomas L. Schwenk. Obsessive-- Compulsive Disorder: Diagnosis and Management[J]. Am Faro Physician, 2009,80(3) : 239-- 245.
8Beth S. Gershuny,Lee Baer,Michael A. Jenike,et al. Comor bid Posttraumatie Stress Disorder: Impact on Treatment Out come for Obsessive--Compulsive Disorder[J]. Am J Psyehia try, 2002,159 (5) : 852 -- 854.
9Cath DC,Spinhoven P, Landman AD, et al. Psychopathology and personality characteristics in relation to blood serotonin in Tourette's syndrome and obsessive sompulsive disorder[J]. J Psychopharmacol, 2001,15 (2) :111--119.
